Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / App Notes / 2021 / A quick and robust mass spectrometry-based method for the detection of SARS-CoV-2

A quick and robust mass spectrometry-based method for the detection of SARS-CoV-2

11/15/2021

Share

 

To develop a robust, quick, and reliable method using the Thermo Scientific™ TSQ Altis™ MD mass spectrometer to allow the absolute quantitation of peptides from SARS-CoV-2 enzymatic digestions.

 

 

  • Simple offline sample preparation, with high recovery
  • Reliable detection and absolute quantification of peptides from digested SARS-CoV-2 spike and nucleocapsid proteins
  • down to low/sub-femtomole on-column concentrations
  • Highlights the viability of two different sample matrices

 

 

The development of a bottom-up proteolytic workflow has been demonstrated as a reliable means of detection for SARS-CoV-2 peptides that are biomarkers of an active COVID-19 infection.1 In this technical note, a quick and robust mass spectrometry-based method for the detection of such biomarkers is reported. Six peptides were observed from recombinant protein samples that were spiked either onto nasopharyngeal swabs or into saliva, placed in viral transport media, and enzymatically digested. Sub/low-femtomole on-column detection and quantification limits were observed for each peptide, demonstrating the feasibility of using a TSQ Altis MD mass spectrometer for COVID-19 testing.

 

 

>> Download the Application Note as a PDF

 

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Fast and automated TSA-based multiplexed immunofluorescence on LabSat® Research

February 15, 2021

A single NGS workflow for comprehensive genomic profiling

February 23, 2021

Biomarker Optimization on LabSat® Research

March 23, 2021

Fully automated quantification of Meropenem, Tazobactam, Piperacillin and Dexamethasone in plasma

May 4, 2021

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.